CHEK2 genomic and proteomic analyses reveal genetic inactivation or endogenous activation across the 60 cell lines of the US National Cancer Institute.

CHEK2 genomic and proteomic analyses reveal genetic inactivation or endogenous activation across the 60 cell lines of the US National Cancer Institute.

Item
http://www.wikidata.org/entity/Q39505275
Trial Watch: Targeting ATM-CHK2 and ATR-CHK1 pathways for anticancer therapyX-ray structures of checkpoint kinase 2 in complex with inhibitors that target its gatekeeper-dependent hydrophobic pocketStructural characterization of inhibitor complexes with checkpoint kinase 2 (Chk2), a drug target for cancer therapyTargeting of Chk2 as a countermeasure to dose-limiting toxicity triggered by topoisomerase-II (TOP2) poisonsFunctional categories associated with clusters of genes that are co-expressed across the NCI-60 cancer cell linesConcordance of gene expression and functional correlation patterns across the NCI-60 cell lines and the Cancer Genome Atlas glioblastoma samples.CHEK2 (∗) 1100delC Mutation and Risk of Prostate Cancer.CellMiner: a web-based suite of genomic and pharmacologic tools to explore transcript and drug patterns in the NCI-60 cell line set.CHEK2 mutation and risk of prostate cancer: a systematic review and meta-analysis.Phenotypic and Molecular Characterization of MCF10DCIS and SUM Breast Cancer Cell Lines.The exomes of the NCI-60 panel: a genomic resource for cancer biology and systems pharmacology.Versatile in vivo regulation of tumor phenotypes by dCas9-mediated transcriptional perturbation.Transcription poisoning by Topoisomerase I is controlled by gene length, splice sites, and miR-142-3p
P2860

CHEK2 genomic and proteomic analyses reveal genetic inactivation or endogenous activation across the 60 cell lines of the US National Cancer Institute.

Item
http://www.wikidata.org/entity/Q39505275
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
CHEK2 genomic and proteomic an ...... US National Cancer Institute.
@en
CHEK2 genomic and proteomic an ...... US National Cancer Institute.
@nl
type
label
CHEK2 genomic and proteomic an ...... US National Cancer Institute.
@en
CHEK2 genomic and proteomic an ...... US National Cancer Institute.
@nl
prefLabel
CHEK2 genomic and proteomic an ...... US National Cancer Institute.
@en
CHEK2 genomic and proteomic an ...... US National Cancer Institute.
@nl
P1433
P1476
P2093
P2860
P2888
P304
P31
P356
P407
P433
P478
P50
P577
P5875
P698
P356
P1433
P1476
CHEK2 genomic and proteomic an ...... e US National Cancer Institute
@en
P2093
P2860
P2888
P304
P31
P356
P407
P433
P478
P50
P577
P5875
P698